MedPath

Acerus Pharmaceuticals Corporation

🇨🇦Canada
Ownership
-
Employees
-
Market Cap
-
Website

Clinical Trials

10

Active:0
Completed:7

Trial Phases

4 Phases

Phase 1:3
Phase 2:4
Phase 3:1
+1 more phases

Drug Approvals

1

FDA:1

Drug Approvals

Natesto

Approval Date
Dec 19, 2022
FDA

Clinical Trials

Distribution across different clinical trial phases (10 trials with phase data)• Click on a phase to view related trials

Phase 2
4 (40.0%)
Phase 1
3 (30.0%)
Phase 4
2 (20.0%)
Phase 3
1 (10.0%)

A Study to Monitor Ambulatory Blood Pressure Monitoring in Hypogonadal Men Treated With Nasal Testosterone Gel

Phase 4
Conditions
Hypogonadism
Interventions
First Posted Date
2021-07-26
Last Posted Date
2022-07-06
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
218
Registration Number
NCT04976595
Locations
🇺🇸

Alabama Clinical Therapeutics, Birmingham, Alabama, United States

🇺🇸

Horizon Clinical Research Associates, Phoenix, Arizona, United States

🇺🇸

Eclipse Clinical Research, Tucson, Arizona, United States

and more 27 locations

Open-Label Study, Evaluating Patient Satisfaction and Symptom Improvement When Treating Male Hypogonadism With Natesto™

Phase 4
Completed
Conditions
Hypogonadism
Interventions
First Posted Date
2016-10-19
Last Posted Date
2019-08-12
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
117
Registration Number
NCT02937740
Locations
🇨🇦

Prostate Cancer Centre - Research, Calgary, Alberta, Canada

🇨🇦

Silverado Research Inc., Victoria, British Columbia, Canada

🇨🇦

LMC Barrie, Barrie, Ontario, Canada

and more 8 locations

Efficacy and Safety of TBS-2 Testosterone Gel in Women With Acquired Female Orgasmic Disorder

Phase 2
Completed
Conditions
Female Orgasmic Disorder
Interventions
Drug: Placebo
Drug: High dose TBS-2
Drug: Medium dose TBS-2
Drug: Low dose TBS-2
First Posted Date
2012-05-30
Last Posted Date
2018-08-13
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
253
Registration Number
NCT01607658
Locations
🇺🇸

Radiant Research, Akron, Ohio, United States

🇺🇸

Medical Affiliated Research Center Inc., Huntsville, Alabama, United States

🇺🇸

Radiant Research Inc., San Antonio, Texas, United States

and more 44 locations

Safety and Efficacy of Intranasal TBS-1 Treatment of Male Hypogonadism

Phase 3
Completed
Conditions
Male Hypogonadism
Interventions
First Posted Date
2011-10-04
Last Posted Date
2018-06-13
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
306
Registration Number
NCT01446042
Locations
🇺🇸

Alabama Clinical Therapeutics LLC, Birmingham, Alabama, United States

🇺🇸

Medical Affiliated Research Center, Inc., Huntsville, Alabama, United States

🇺🇸

Coastal Clinical Research, Mobile, Alabama, United States

and more 27 locations

PK Study of Testosterone Nasal Gel (TBS-2) in Healthy Premenopausal Women

First Posted Date
2011-06-02
Last Posted Date
2019-10-16
Lead Sponsor
Acerus Pharmaceuticals Corporation
Target Recruit Count
24
Registration Number
NCT01364623
Locations
🇺🇸

Premier Research International LLC, Austin, Texas, United States

  • Prev
  • 1
  • 2
  • Next

News

No news found

MedPath

Empowering clinical research with data-driven insights and AI-powered tools.

© 2025 MedPath, Inc. All rights reserved.